Categories: Technology

Tenable Announces the Passing of Chairman and CEO Amit Yoran

 | Source: Tenable Holdings, Inc.

COLUMBIA, Md., Jan. 04, 2025 (GLOBE NEWSWIRE) — It is with profound sadness that Tenable Holdings, Inc. announces the passing of our Chairman and Chief Executive Officer, Amit Yoran. Amit passed away unexpectedly yesterday. He had been battling cancer.

A visionary leader and a pioneer in the cybersecurity industry, Amit dedicated his life to making the digital world safer. His unwavering commitment to innovation and relentless pursuit of excellence transformed Tenable into a global leader in exposure management. His contributions to the field have left an indelible mark, not only on the company but on the broader cybersecurity community.

“Amit was an extraordinary leader, colleague, and friend,” said Art Coviello, Tenable’s lead independent director. “His passion for cybersecurity, his strategic vision, and his ability to inspire those around him have shaped Tenable’s culture and mission. His legacy will continue to guide us as we move forward.”

Amit Yoran joined Tenable as CEO in 2016, leading the company through significant growth, including its successful initial public offering in 2018. Prior to Tenable, Amit held several prominent positions, including President of RSA and founding CEO of NetWitness, among many other leadership roles in the technology sector.

Amit took a medical leave of absence starting December 5, 2024 at which time the Board appointed Steve Vintz, CFO, and Mark Thurmond, COO, as Co-CEOs to ensure continued strategic execution and stability. The company will continue to operate under their leadership as the Board conducts a CEO search, including both internal and external candidates. Art Coviello will serve as Chairman of the Board.

Based on our preliminary results for the Q4 and the full year, the company expects to meet or exceed the financial guidance we provided in the press release issued on Oct. 30, 2024.

Our thoughts are with Amit’s family during this difficult time. We extend our deepest condolences to his loved ones and express our gratitude for the remarkable legacy he leaves behind. Funeral arrangements have not been announced at this time.

About Tenable
Tenable® is the exposure management company, exposing and closing the cybersecurity gaps that erode business value, reputation and trust. The company’s AI-powered exposure management platform radically unifies security visibility, insight and action across the attack surface, equipping modern organizations to protect against attacks from IT infrastructure to cloud environments to critical infrastructure and everywhere in between. By protecting enterprises from security exposure, Tenable reduces business risk for approximately 44,000 customers around the globe. Learn more at tenable.com.

Media Contact:  
Brian Alberti
Tenable
tenablepr@tenable.com

Forward-Looking Statements
This press release includes forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release other than statements of historical fact, including statements regarding our results of operations for Q4 and full year 2024 are forward-looking statements and represent our views as of the date of this press release. The words “anticipate,” “believe,” “continue,” “estimate,” “expect,” “intend,” “may,” “will” and similar expressions are intended to identify forward-looking statements. We have based these forward-looking statements on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy, short-term and long-term business operations and objectives and financial needs. These forward-looking statements are subject to a number of assumptions and risks and uncertainties, many of which involve factors or circumstances that are beyond our control that could affect our financial results. These risks and uncertainties are detailed in the sections titled “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the year ended December 31, 2023 as well as other filings that we make from time to time with the SEC, which are available on the SEC’s website at sec.gov. Moreover, we operate in a very competitive and rapidly changing environment. New risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. In light of these risks, uncertainties and assumptions, the future events and trends discussed in this press release may not occur and actual results could differ materially and adversely from those anticipated or implied in any forward-looking statements. Except as required by law, we are under no obligation to update these forward-looking statements subsequent to the date of this press release, or to update the reasons if actual results differ materially from those anticipated in the forward-looking statements.

GlobeNews Wire

Recent Posts

Chery Debuts All-New HIMLA Series at 2025 Shanghai Auto Show, Redefining the Pickup Market with Full-Category Lineup

SHANGHAI, April 26, 2025 /PRNewswire/ -- On April 23, under the spotlight at 2025 Shanghai…

8 hours ago

Protara Therapeutics Announces Positive Interim Results Demonstrating Durable Responses in the Ongoing Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC

April 26, 2025 10:00 ET  | Source: Protara Therapeutics TARA-002 demonstrates 100% complete response rate…

10 hours ago

RAD-140 SARMs Rad 140 Testolone Benefits, Dosage, Safety, and Where to Buy Sarms Online (by Crazy Bulk USA)

NEW YORK, April 26, 2025 (GLOBE NEWSWIRE) -- The fitness and bodybuilding industry is constantly…

10 hours ago

Prime Biome (Ive Tested It for 90 Days) Heres My Honest Prime Biome Gummies Review And Shocking Results! (Good, Bad & Real)

LOS ANGELES, April 26, 2025 (GLOBE NEWSWIRE) -- Prime Biome is a rigorously developed herbal…

10 hours ago

GenVivo Highlights GEN-1013: A Novel Delivery of an IL-12 Immunotherapy at the 2025 American Association for Cancer Research (AACR) Annual Meeting

GEN-1013 was studied in an aggressive CT26 murine cancer model using both IT and IV…

10 hours ago

Burnjaro Under Review: Analyzing the Results of Burn Jaro Slimming Ingredients to Instantly Burn Belly Fat

Norcross, Georgia, April 26, 2025 (GLOBE NEWSWIRE) -- In This Article, You’ll Discover: Why belly…

10 hours ago